Low dose rituximab efficiently clears circulating CLL cells and maintains sensitivity to antibody dependent cellular cytotoxicity (ADCP)Clive Zent, Clare Heffernan,Charles Chu, Jennifer Bruno, Christine Herne,Andrea Baran,Ronald Taylor,Paul Barr, Michael ElliottLEUKEMIA & LYMPHOMA(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要